白介素15(IL15)多克隆抗體
Polyclonal Antibody to Interleukin 15 (IL15)
- 編號PAA061Gu01
 - 物種Cavia (Guinea pig ,豚鼠)相同的名稱,不同的物種。
 - 來源多抗制備
 - 宿主兔
 - 效價-
 - Ig類型IgG
 - 純化方式抗原特異性親和純化
 - 標記物無標記物
 - 免疫原-
 - 緩沖液成份磷酸鹽緩沖液(pH7.4,含有0.02% NaN3和50%甘油)
 - 性狀液體
 - 濃度500μg/mL
 - 且適物種-
 - 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術,請參見流式抗體。 - 下載英文說明書 中文說明書
 - 規(guī)格20μl100μl200μl1ml10ml
 - 價格¥ 648¥ 1512¥ 2160¥ 5400¥ 21600
 - 欲了解實際交易價格和更多情況,請與當地經銷商聯系!
 
特異性
該抗體是針對IL15的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別IL15。
用法
                        免疫印跡:0.2-2μg/mL;1:250-2500
                        
 免疫組織化學:5-20μg/mL;1:25-100
                        
 免疫細胞化學:5-20μg/mL;1:25-100
                        
 最佳稀釋倍數最終由用戶決定。
                        
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當的條件下存儲,損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種:Cavia (Guinea pig ,豚鼠) | 應用(僅供研究使用,不用于臨床診斷!) | 
| RPA061Gu01 | 白介素15(IL15)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAA061Gu01 | 白介素15(IL15)多克隆抗體 | WB; IHC; ICC; IP. | 
參考文獻
| 雜志 | 參考文獻 | 
| Endocrine | Expression of interleukin-15 and inflammatory cytokines in skeletal muscles of STZ-induced diabetic rats: effect of resistance exercise training[Pubmed: 24006180] | 
| Endocrine | Time course of IL-15 expression after acute resistance exercise in trained rats: effect of diabetes and skeletal muscle phenotype[Pubmed:25522723] | 
| Med Sci Moni | miR-15b is Downregulated in Myasthenia Gravis Patients and Directly Regulates the Expression of Interleukin-15 (IL-15) in Experimental Myasthenia Gravis Mice[PubMed: 26087886] | 
| Exercise physiology | Effects of intrinsic aerobic capacity, aging and physical activity on interleukin-15 protein level in serum and skeletal muscle[Dspace: Handle] | 
| Biotechnology Letters | Novel adjuvant for immunization against tuberculosis: DNA vaccine expressing Mycobacterium tuberculosis antigen 85A and interleukin-15 fusion product elicits strong immune responses in mice[s10529-017-2342-1] | 
| Journal?of?Controlled?Release | Interleukin-15 and cisplatin co-encapsulated thermosensitive polypeptide hydrogels for combined immuno-chemotherapy.[pubmed:28408199] | 



